3PAAVONEN J,STAMM WE.Sexually transmitted diseases:lower genital tract infections in women[J].Infect Dis Clin North Am,1987,1(1):179-198.
4HURLEY R,de LOUVOIS J.Candida vaginitis[J].Postgrad Med J,1979,55(647):645-647.
5ROSA MI,SILVA BR,PIRES PS,et al.Weekly fluconazole therapy for recurrent vulvovaginal candidiasis:a systematic review and meta-analysis[J].Eur J Obstet Gynecol Reprod Biol,2013,167(2):132-136.
6FDA.Guidance for industry:developing antimicrobial drugs—general considerations for clinical[EB/OL].(1998-07-22)[2014-04-14].http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm070983.pdf.
7FDA.Guidance for industry.Evaluating clinical studies of antimicrobials in the division of anti-infective drugs products[EB/OL].(1997-02-17)[2014-04-14].http://www.fda.gov/downloads/Drugs/Guidance Compliance Regulatory Information/Guidances/UCM071162.pdf.
8DAVID HU,FREDERICK L,CATHLEEN AL,et al.Singledose miconazole nitrate vaginal ovule in the treatment of vulvovaginal candidiasis:two single-blind,controlled studies versus miconazole nitrate 100 mg cream for 7 days[J].J Womens Health Gend Based Med,2000,9(4):421-429.
9FDA.Guidance for industry.Vulvovaginal candidiasis—developing antimicrobial drugs for treatment[EB/OL].(1998-07-22)[2014-04-01].http://www.fda.gov/downloads/Drugs/Guidance-Compliance Regulatory Information/Guidances/UCM071204.pdf.
